PCSK9 and fatty liver disease: PCSK9 knockout (KO) mice develop severe hepatic steatosis when fed a high-fat diet [53, 54], since PCSK9 reduces the expression of fatty acid translocase also known as CD36, a scavenger receptor for fatty acid uptake and the main driver of their uptake in the liver.